| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Gheuens Sarah is a Chief Medical Officer at AGIOS PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2024 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 642 | $25.14 | $16,139.88 | -1.9% | +31.8% | +28.6% | |
| Jan 24, 2024 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 1,708 | $21.64 | $36,961.12 | -5.1% | +47.9% | +64.5% | |
| Jan 9, 2024 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 1,789 | $22.99 | $41,129.11 | -6.0% | +15.4% | +49.6% | |
| Jun 30, 2023 | AGIO Agios Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 1,707 | $28.36 | $48,410.52 | -6.6% | -12.5% | +52.3% |